In this upbeat interview, CEO Sandy Chadha of Supreme takes me through today’s upgraded FY'24 EBITDA guidance of between £28m-£30m (+13% vs prior consensus £25.6m & +49.5% LY £19.4m) on sales 28% higher at £195m-£205m vs LY £155.6m.
Disclosure: Vox Markets paid me to intevriew Supreme.
Stocks owned : EQLS, AGFX, Pfizer, Bristol Myers, Roche, WATR, VCT, MBH, ASTO, IOM, TR25, ESYS, ELCO, IHC, Paypal & AOM Elsewhere, I'm also paid by Vox Markets (as a contractor) to interview interview fund managers, capital market experts & companies (re EQLS, VRCI, BELL, FIN, AVG, AVCT, LLAI, VLG, FADL, SUP, ELCO, LORD , MPAC & ONC). I believe all these stocks are clients of Vox.Lastly my 24 year HIT RATE is only 62%. Meaning 38% of the time I lose money (ie often wrong) - albeit my winners are (on average) 1.5x larger than my losers. Please Do Your Own Research. more »
